A new BCAA product featuring the IPH AGAA peptide complex has been launched in Germany, known for its stringent quality standards for dietary supplements. Ideal Pharma Peptide, in collaboration with Peptiline, has introduced “BCAA MIT PEPTID-KOMPLEX IPH AGAA” to the European market, incorporating their signature IPH peptide complexes into the formulation.
This innovative product has undergone rigorous testing in Germany and is approved for sale across the European Union, meeting the high regulatory standards set by the region.